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Abstract
Background: The purpose of this study was to confirm that women with latent toxoplasmosis
have developmentally younger fetuses at estimated pregnancy week 16 and to test four exclusive
hypotheses that could explain the observed data.
Methods: In the present retrospective cohort study we analysed by the GLM (general linear
model) method data from 730 Toxoplasma-free and 185 Toxoplasma-infected pregnant women.
Results: At pregnancy week 16 estimated from the date of the last menstruation, the mothers with
latent toxoplasmosis had developmentally younger fetuses based on ultrasound scan (P = 0.014).
Pregnancy of Toxoplasma-positive compared to Toxoplasma-negative women was by about 1.3 days
longer, as estimated both from the date of the last menstruation (P = 0.015) and by ultrasonography
(P = 0.025).
Conclusion: The most parsimonious explanation for the observed data is retarded fetal growth
during the first weeks of pregnancy in Toxoplasma-positive women. The phenomenon was only
detectable in multiparous women, suggesting that the immune system may play some role in it.
Background
Toxoplasmosis, a zoonosis caused by a protozoan, Toxo-
plasma gondii, is probably the most widespread human
parasitosis. In immunocompetent humans, postnatally
acquired toxoplasmosis is either inapparent, or accompa-
nied by cervical lymphadenopathy with fever, joint pain,
headache and tiredness [1,2]. The acute disease promoted
by rapidly dividing tachyzoites usually spontaneously
proceeds to the latent toxoplasmosis. During latent toxo-
plasmosis the parasite survives in the form of slowly
dividing bradyzoites in tissue cysts, usually providing
immunity against reinfection for the rest of the host life.
Latent toxoplasmosis is generally considered to be asymp-
tomatic from the clinical point of view; however, it is
accompanied by specific changes in personality profiles of
the infected subjects [3]. The most damaging form of tox-
oplasmosis is congenital toxoplasmosis. In pregnant
women with the acute form of infection, the parasite can
infect the placenta and, after a lag period, also the fetus.
The pathology of the infected newborn has been exten-
sively reviewed. The classical Sabin's triad of symptoms of
intrauterine toxoplasmosis includes hydrocephalus,
intracranial calcification, and chorioretinitis [4]. Approxi-
mately 20% of infants born with congenital infection
have severe disease. Another about 70% are asymptomatic
at birth but can develop clinical signs in the later years, i.e.
slower neurological and mental development and late
chorioretinitis [5].
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For pregnant women with latent toxoplasmosis neither
pathological changes in newborns nor health damage due
to toxoplasmosis in mothers have been reported. It was
speculated about possible effects of latent toxoplasmosis
on the risk of abortion [6]; however, this speculation has
not been confirmed in recent studies [7,8]. Women
infected with parasite Toxoplasma have more sons [9]. In a
large cross-section study performed on a sample of 1,736
clients of three obstetrics and gynaecology clinics, the sex
ratio (the probability of the birth of a boy) increased up
to the value of 0.71, which means that women with the
highest concentration of anti-Toxoplasma antibodies (and
therefore probably recent infection) gave birth to 250
boys per 100 girls. Moreover, slower fetal development
was observed at estimated pregnancy week 16 in women
with latent toxoplasmosis based on ultrasonography [10].
Several explanations for this phenomenon were sug-
gested, including retarded fetal growth in Toxoplasma-
infected women. The aims of the present study were to
confirm the retarded fetal development in an independ-
ent retrospective cohort study, and to test four exclusive
hypotheses that could explain the observed data:
Hypothesis 1
In infected women the fetal development is slower but the
delivery does not take place until the fetus reaches the
usual birth parameters, e.g. birth weight and length.
Therefore infected women are likely to have longer preg-
nancy as estimated both from the date of the last menstru-
ation and based on ultrasonography.
Hypothesis 2
In infected women, the fetal development is slower but
pregnancy duration is still 280 days on average as in Tox-
oplasma-free women independently of the child's size at
birth. Therefore infected women are likely to have the
same pregnancy length as Toxoplasma-free women esti-
mated based on the date of the last menstruation and
shorter pregnancy estimated based on the first ultrasonog-
raphy. Infants of infected women are likely to have lower
birth weight.
Hypothesis 3
In infected women, ovulation occurs in the later phase of
the menstruation cycle. Therefore the first ultrasonogra-
phy shows correctly the fetal age, pregnancy duration esti-
mated based on ultrasonography is the same as in women
without toxoplasmosis but the pregnancy duration esti-
mated from the date of the last menstruation is longer.
Hypothesis 4
Women with and without toxoplasmosis differ from each
other in the secondary sex ratio [9] and the reported dif-
ference between growth curves for male and female
fetuses explains the slower fetal development in infected
women at pregnancy week 16. Therefore no differences in
fetal age and pregnancy length will be observed between
Toxoplasma-infected and Toxoplasma-free women at preg-
nancy week 16 when the male and female fetuses are stud-
ied separately.
In our cohort study, we analysed clinical records of 1,035
pregnant women tested for the presence of anamnestic
antibodies against Toxoplasma to decide which of the four
above mentioned hypotheses best corresponds to the
empirical data.
Methods
The experimental set consisted of clients of two private
clinics (Centres of Reproductive Medicine in Prague 5 and
Prague 8). The experimental design was a cohort study.
With the help of the personnel from these clinics, anony-
mous data was collected on the progress of 1,053 preg-
nancies. The original data set included records of all
clients tested for toxoplasmosis from 1996–2004 who
were Czech citizens and inhabitants of the city of Prague.
Women were serologically tested for toxoplasmosis at
about pregnancy week 16. The presence of anamnestic
antibodies against Toxoplasma  was diagnosed with the
indirect immunofluorescence test (IIFT) at dilutions
between 1:8 and 1:1024. The samples with specific fluo-
rescence visible in a 1:16 or higher dilution was consid-
ered as Toxoplasma-positive. In the study set, 208 women
tested Toxoplasma-positive (prevalence of 19.8%). Clinical
records comprised maternal antibody titres, age, number
of previous deliveries, number of previous abortions,
newborn's sex and birth weight and length, date of the last
menstruation, pregnancy length estimated based on the
first ultrasonography (mostly between pregnancy weeks 8
and 12), and bioparameter data from fetal ultrasonogra-
phy (biparietal diameter, abdominal circumference,
femur length) done approximately at pregnancy weeks 20
and 30. The data on the last menstruation can be affected
by stochastic errors; however, stochastic errors cannot be
responsible for false positive results.
The average maternal age was 30 (19–44). Thirty-six
women gave birth to twins, with 7 of them being Toxo-
plasma-infected. The data set included 642, 342, 58, 10
and 1 records concerning newborns from the first, second,
third, fourth and fifth pregnancy, respectively. Data on the
twins were excluded from the data set. Given that some
records were incomplete, 66 women with missing data
were excluded from the respective analyses. For example,
some women were excluded because of the missing data
on pregnancy length estimated based on ultrasonography
at pregnancy week 16 (43 cases), suspected acute toxo-
plasmosis, i.e. high IgM and IgA titres (2 cases) or proba-
ble error in the date of the last menstruation when the
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sonography and from the date of the last menstruation
was greater than 20 days (21 cases).
The influence of toxoplasmosis on pregnancy length at
pregnancy week 16 estimated based on the first ultra-
sonography was evaluated by the GLM (general linear
model) method. Independent variables in the model were
the binary variable TOXO and continuous variables
maternal age and pregnancy length estimated from the
last menstruation. The GLM model was also used for stud-
ying the effects of toxoplasmosis (independent variable
TOXO) and maternal age (independent continuous varia-
ble), on the newborn's birth length and weight, fetal bio-
parameters measured by ultrasonography at pregnancy
weeks 20 and 30, and pregnancy length. The continuous
variable pregnancy length estimated from the date of the
last menstruation was included into the model used for
testing the effect of toxoplasmosis on fetal bioparameters.
Women with preterm delivery (pregnancy length less than
266 days [10]), were excluded from testing for the influ-
ence of latent toxoplasmosis on overall pregnancy length
estimated both based on ultrasonography and from the
date of the last menstruation. All statistical testing includ-
ing the evaluation of statistical test assumptions (normal-
ity of data distribution, normality of residuals and
homogeneity of variances) were done using the Statistica®
6.0 software. The study was approved by the IRB of the
Faculty of Science, Charles University, and complied with
the current laws of the Czech Republic.
Results
The influence of toxoplasmosis on pregnancy length at
pregnancy week 16 estimated based on the first ultra-
sonography was evaluated by the GLM in the set of 915
mothers. The result showed that 185 Toxoplasma-infected
subjects had a shorter pregnancy (111.56 days) than 730
Toxoplasma-free subjects (112.59 days) (F1,911 = 6.1, P =
0.0137). The continuous predictors in the model were
also significant: maternal age (F1,911 = 4.0, P = 0.0456),
and presumptive pregnancy length estimated from the
date of the last menstruation (F1,911 = 484.0, P < 0.0001).
The same model was used for evaluating the effects of tox-
oplasmosis separately in women with male and female
offspring. In both cases the influence of latent toxoplas-
mosis on pregnancy length was significant in one-tailed
tests (male newborns: n = 507, F1,503 = 3.5, P1 = 0.0313,
female newborns: n = 396, F1,392 = 2.9, P1 = 0.0459). The
separate tests for primiparous and multiparous women
showed that the effect of toxoplasmosis was significant for
multiparous women (n = 362, F1,358 = 5.8, P = 0.0164),
Differences in pregnancy length estimated based on ultrasonography at pregnancy week 16 (estimated from the date of the last  menstruation) between Toxoplasma-infected and Toxoplasma-free women Figure 1
Differences in pregnancy length estimated based on ultrasonography at pregnancy week 16 (estimated from the date of the last 
menstruation) between Toxoplasma-infected and Toxoplasma-free women. Left graph, primparas (P = 0.2546), right graph, mul-
tiparas (P = 0.0164).BMC Infectious Diseases 2007, 7:114 http://www.biomedcentral.com/1471-2334/7/114
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while for primiparous women this effect was not signifi-
cant (n = 553, F1,549 = 1.3, P = 0.2546) (Figure 1).
Toxoplasmosis had no effect on fetal bioparameters meas-
ured by ultrasonography at pregnancy weeks 20 and 30 in
both the whole study set (Table 1) and the subset of mul-
tiparous women (not shown). Similarly, toxoplasmosis
had no effect on newborn's birth length and weight both
in the whole study set: birth length (n = 784, F1,780 = 1.6,
P = 0.2071, averages: 50.47 cm in Toxoplasma-infected and
50.66 cm in Toxoplasma-free women), birth weight (n =
962, F1,958 = 0.00, P = 0.9872, averages: 3497.61 g in Tox-
oplasma-infected and 3493.44 g in Toxoplasma-free
women) and in the subset of multiparous women: birth
length (n = 324, F1,320 = 2.9, P = 0.0873, averages: 50.30
cm in Toxoplasma-infected and 50.77 cm in Toxoplasma-
free women), birth weight (n = 398, F1,394 = 0.23, P =
0.6284, averages: 3499.61 g in Toxoplasma-infected and
3535.18 g in Toxoplasma-free women).
Toxoplasma-infected women had longer pregnancy than
Toxoplasma-free women (281.03 vs. 279.82 days, based on
ultrasonography) (283.02 vs. 281.65 days, based on the
date of the last menstruation) (Figures 2 and 3). The
effects of toxoplasmosis and maternal age on pregnancy
length were significant (based on ultrasonography: n =
884, F1,881 = 5.0, P = 0.0256, maternal age: F1,881 = 4.3, P =
0.0378), (based on the date of the last menstruation: n =
871, F1,868 = 5.9, P = 0.0151, maternal age: F1,868 = 18.0, P
= 0.0001). To estimate influence of available confounding
variables and interactions, we also analysed two models
with independent variables TOXO, newborn's SEX and
PARITY (0 – primipara, 1 – multipara), and the dependent
variable pregnancy length estimated either based on ultra-
sonography or from the date of the last menstruation. The
effect of TOXO on pregnancy length estimated both based
on ustrasonography and from the date of last menstrua-
tion was significant (pregnancy lengthUSG: n = 882, F1,873
= 4.9, P = 0.0264, maternal age F1,873 = 3.9, P = 0.0491,
newborn's SEX F1,873 = 0.9, P = 0.3303, PARITY F1,873 = 1.5,
P = 0.199; pregnancy lengthLM: n = 869, F1,860 = 6.1, P =
0.0138, mother's age F1,860 = 16.6, P = 0.0001, newborn's
SEX F1,860 = 0.2, P = 0.674, PARITY F1,860 = 0.6, P = 0.663).
On the other hand, no effect of interaction, including
TOXO-PARITY and TOXO-newborn's SEX, was significant
in any model.
Discussion
The results confirmed the already reported differences in
the early fetal development between Toxoplasma-infected
and  Toxoplasma-free women. As for our four proposed
hypotheses, the obtained data confirm hypothesis No. 1
that assumes the slower fetal development in women with
toxoplasmosis with the determination of pregnancy
length based on fetal bioparameters. Hypotheses No. 2
and 3 can be rejected on the basis of the observed differ-
ences in pregnancy length between Toxoplasma-infected
and Toxoplasma-free women and Hypothesis No. 4 was
disproved on the basis of positive results of the analysis
performed separately for the male and female offspring.
The slower fetal development in infected women can be
explained at least by three principally different proximal
mechanisms.  Toxoplasma  could directly retard the fetal
development or could shift the moment of the implanta-
tion of the blastocyst or reduce the stringency of embryo
quality control, thus allowing fetuses with mild develop-
mental disorders to escape it. Retarded fetal development
could be a result of subclinical health impairment in Tox-
oplasma-infected women. Chronic pathogenic processes
can affect the circulation of blood in the uterus and mater-
nal part of the placenta with consequent fetal malnutri-
tion [11]. Toxoplasmosis could cause defects in the
general metabolism and fetal growth in Toxoplasma-
Table 1: Fetal ultrasonography data in Toxoplasma-infected and Toxoplasma-free women at pregnancy weeks 20 and 30
20th week of the gravidity 30th week of the gravidity
BPD AC FL BPD AC FL
n (toxo.neg./toxo.poz.) 952 (760/192) 925 (378/187) 952 (760/192) 940 (750/190) 913 (727/186) 937 (747/190)
F 0.0 1.4 3.1 0.2 0.0 1.0
P 1 0.2432 0.0781 0.6291 0.8679 0.3124
Mean (SE) toxo. neg. 48.94(0.14) 153.27(0.53) 34.58(0.12) 78.21(0.13) 266.64(0.56) 58.71(0.12)
toxo. poz. 49.01(0.26) 152.57(0.98) 34.97(0.23) 78.41(0.24) 267.18(1.05) 59.00(0.21)
maternal age F 12.8 16.2 4.3 24.0 31.5 22.2
P 0.0004 < 0.0001 0.0388 < 0.0001 < 0.0001 < 0.0001
pregnancy 
length
F 860.2 864.9 687.7 592.0 467.2 589.2
P < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001 < 0.0001
Fetal parameters are shown in millimetres. The results of statistical tests (F and P) were obtained with toxoplasmosis as the independent variable 
and maternal age and pregnancy length estimated from the date of the last menstruation as continuous predictors. BPD – biparietal diameter, AC – 
abdominal circumference, FL – femur length.BMC Infectious Diseases 2007, 7:114 http://www.biomedcentral.com/1471-2334/7/114
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Differences in pregnancy length estimated from the date of the last menstruation between Toxoplasma-infected and Toxo- plasma-free women (P = 0.0151) Figure 2
Differences in pregnancy length estimated from the date of the last menstruation between Toxoplasma-infected and Toxo-
plasma-free women (P = 0.0151).
Differences in pregnancy length estimated based on ultrasonography between Toxoplasma-infected and Toxoplasma-free women  (P = 0.0256) Figure 3
Differences in pregnancy length estimated based on ultrasonography between Toxoplasma-infected and Toxoplasma-free women 
(P = 0.0256).BMC Infectious Diseases 2007, 7:114 http://www.biomedcentral.com/1471-2334/7/114
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infected women. In its early phase, the fetal development
is most susceptible to environmental disturbances [12]. It
is in agreement with our observation, namely with the fact
that the differences between Toxoplasma-infected and Tox-
oplasma-free women were strongest early in pregnancy,
and turned out to be nonsignificant at pregnancy weeks
20 and 30.
The influence of toxoplasmosis on pregnancy was only
observed in multiparous women and remained nonsignif-
icant in primiparous women. It suggests that the maternal
immune system could play some role in the proximate
mechanism of impairment of the fetal development in
Toxoplasma-infected women. Immunological memory is
suspected to be responsible for the differences between
the first pregnancy and the following ones [13,14]. Two
different immunological hypotheses can be suggested for
the effect of toxoplasmosis on pregnancy. The first one
assumes that the changes to the immune system could
delay the implantation of the blastocyst in multiparous
women with toxoplasmosis. The maternal immunoreac-
tivity against the blastocyst is known to play a significant
role in the process of implantation [15]. Toxoplasmosis is
accompanied by the production of immunosuppressive
lymphokines IL-10 and TGF-beta [16,17] that can inter-
fere with the process of immunization. Therefore, Toxo-
plasma-infected women could be less immunized by
antigens on the surface of the blastocyst during the first
pregnancy and consequently, the blastocyst implantation
in later pregnancies could be delayed.
The other hypothesis suggests that Toxoplasma  could
weaken or switch off the mechanism of spontaneous
abortion, normally responsible for removal of embryos
with developmental defects (and also with a slower fetal
growth rate). Some components of the immune system
probably play a role in the effector arm of this quality con-
trol process. Toxoplasmosis is known to be associated
with suppression of the immune system [18]. Due to
immunosuppression, Toxoplasma-infected mothers could
bear to full term more children with developmental
defects. This could explain the smaller fetal size at the first
ultrasonography as well as longer pregnancy in Toxo-
plasma-infected women. The stronger effect of toxoplas-
mosis in multiparous women can result from the previous
immunization by trophoblast or embryonic antigens
leading to generally higher stringency of quality control
mechanisms. In Toxoplasma-free multiparous (and there-
fore immunized) women, most fetuses with any develop-
mental defect are likely to be aborted. In Toxoplasma-
infected women whose immunization against trophob-
last and embryonic antigens is lower (due to Toxoplasma
induced immunosuppression), a higher percentage of
defective embryos are likely to survive.
Most previous studies assumed that the latent toxoplas-
mosis-associated behavioural and physiological changes
are a product of Toxoplasma infection [19]. It cannot be
excluded by any case-control study, however, that Toxo-
plasma infection is in fact only statistically associated with
some unknown socioeconomic or possibly even infection
factor that is responsible for the observed effects. On the
other hand, most toxoplasmosis-associated effects such as
changes in novelty seeking, activity, reaction times and
the secondary sex ratio have been already confirmed by
experimental infection of laboratory mice or rats [19,20].
Therefore, the direct effects of Toxoplasma on the organism
of its host seem to be the most parsimonious explanation
for the observed phenomena.
The effect of latent toxoplasmosis on pregnancy is rather
low. The relatively high statistical significance is partly
caused by the large size of the studied sample (n = 915); it
must be stressed, however, that the effect size estimated
on the basis of the eta squared is less than 1%. The differ-
ence in pregnancy length of 1.3 days seems to be of no
importance for clinical practice. However, the slightly
retarded fetal development could not be the only effect of
latent toxoplasmosis on pregnancy. Nothing is known
either about the possible influence of latent toxoplasmo-
sis in the mother on the postnatal development of her
child. Latent toxoplasmosis affects as many as 84% of
women in some populations [21], while the risk of acute
toxoplasmosis during pregnancy is usually only 1–2%
[22]. Therefore, the impact of latent toxoplasmosis on
public health can be in fact even higher than that of acute
and congenital toxoplasmosis. In this context, more atten-
tion should be paid to the study of effects of this "asymp-
tomatic" form of toxoplasmosis on the prenatal and
postnatal development in the future.
Conclusion
The obtained data confirmed that the fetal development
in Toxoplasma-infected women is slower, but the delivery
does not take place until the fetus reaches the usual birth
parameters, e.g. birth weight and length. The maternal
immune system probably plays a role in the proximate
mechanism of impairment of the fetal development in
Toxoplasma-infected women.
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